Linaglip 5 mg Tablet is an oral antidiabetic medication containing Linagliptin, a DPP-4 inhibitor. It is designed to improve glycemic control in adults with type 2 diabetes mellitus, especially when diet and exercise alone are insufficient. Linaglip can be used as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, pioglitazone, or insulin